Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Up 234.8% in March

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 7,700 shares, a growth of 234.8% from the February 28th total of 2,300 shares. Based on an average daily volume of 38,800 shares, the short-interest ratio is presently 0.2 days.

Reviva Pharmaceuticals Stock Up 3.0 %

Shares of NASDAQ RVPHW opened at $0.05 on Thursday. Reviva Pharmaceuticals has a twelve month low of $0.04 and a twelve month high of $0.78. The stock has a fifty day simple moving average of $0.13 and a 200-day simple moving average of $0.16.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.